University of North Carolina at Chapel Hill at AMP 2026

Nov 10–14, 2026 Seattle, WA ~2k attendees Website

University of North Carolina at Chapel Hill brings 1 presentation to AMP 2026 in Seattle. Its program at the meeting sits in hematologic malignancies and hematopathology. It covers long-read transcriptome sequencing as a way to make molecular diagnostics for pediatric leukemia more accessible.

OrganizationAMP 2026 Attendance
Med centres
Public research university in North Carolina with a medical school, cancer centre and genomics laboratories working on sequencing-based diagnostics.
Talk
Thu, Nov 12
10:15am–10:45am
Long-Read Transcriptome Sequencing Enables Accessible Molecular Diagnostics for Pediatric Leukemia
Nanopore long-read transcriptome sequencing to subtype pediatric acute leukemias by expression signature and fusion detection.
Hematopathology

Explore the full AMP 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Seattle. Leave your work email and we’ll be in touch.

Privacy

Download the full AMP 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University of North Carolina at Chapel Hill

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with the Association for Molecular Pathology. Organization details are derived from AMP’s published lists. Submit a correction